Evolving resistance patterns of Streptococcus pneumoniae: A link with long-acting macrolide consumption?

Journal of Chemotherapy

Volumn 11, Issue SUPPL. 1, 1999, Pages 35-43

  Baquero, F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Alexander Project; Antimicrobial resistance; S. pneumoniae; Surveillance

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; JOSAMYCIN; MACROLIDE; ROXITHROMYCIN; SPIRAMYCIN;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; DRUG CHOICE; NONHUMAN; PENICILLIN RESISTANCE; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032901142     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.supplement-2.35     Document Type: Conference Paper

References (23)

1. Grüneberg RN, Felmingham D and the Alexander Project Group. Results of the Alexander Project: a continuing multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 1996; 25: 169-181.
2. Brelmann RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271: 1831-1835.
3. Schito GC, Manelli S, Pesce A and the Alexander Project Group. Trends in the activity of macrolide and β-lactam antibiotics and resistance development. J Chemother 1997; 9 (Suppl 3): 18-28.
4. Bottger EC. Resistance to drugs targeting protein synthesis in mycobacteria. Trends Microbiol 1994 Oct; 2: 416-21.
5. Baquero F. 1996 Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J Antimicrob Chemother 38 (Suppl A): 117-132.
6. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotilala A, Helenius H, Lager K, Huovinen P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441-446.
7. Felmingham D, Grüneberg RN. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens 1992-1993: the Alexander Project. J Antimicrob Chemother 1996; 38 (Suppl A): 1-58.
8. Geslin P, Buu-Hoi A, Frémaux A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis 1992; 15: 95-98.
9. Perez-Trallero E, Urbieta M, Montes M, Ayestaran I, Marimon JM. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infect Dis 1998; 17: 25-31.
10. Fenoll A, Martin Bourgon C, Munoz R, Vicioso D, Casai J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991; 13(1): 56-60.
11. Linares J, Pallares R, Alonso T, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992; 15(1): 99-105.
12. Aszkenasy OM, George RC, Begg NT. Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992. Commun Dis Rep CDR Rev 1995; 5(4): R45-50.
13. Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. J Infect Dis 1991; 163(6): 1273-8.
14. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333(8): 481-6.
15. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995; 14(9): 745-50.
16. Butler JC, Hofmann J, Cetron MS, Elliort JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174(5): 986-93.
17. Moreno S, Garcia-Leoni ME, Cercenado E, et al. Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study. Clin Infect Dis 1995; 20(5): 1195-200.
18. Martinez-Martinez L, Lopez-Hernandez I, Pascual A, Suarez AI, Perea EJ. Resistance of Streptococcus pneumoniae to penicillin, erythromycin and third-generation cephalosporins in Seville, Southern Spain. Clin Microbiol Infect 1997; 3: 382-85.
19. Geslin P, Fremaux A, Sissia G, Spicq C, Aberrane S. Epidemiology of pneumococcal resistance to antibiotics in France. National Cooperative Survey (1984-1993). Epidemiologie de la resistance aux antibiotiques de Streptococcus pneumoniae en France. Reseau national de surveillance (1984-1993). Med Mal Infect 1994; 24: Special, 948-61.
20. del Castillo F, Baquero-Artigao F, Garcia-Perea A. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatr Infect Dis J 1998; 17(2): 94-7.
21. Baquero F, Negri M. Strategies to minimize the development of antibiotic resistance. J Chemother 1997; 9 (Suppl 3): 29-37.
22. Drusano GL; Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J Chemother 1997; 9 (Suppl 3): 38-44.
23. Pankuch GA, Jueneman SA, Davies TA, Jacobs MR, Appelbaum PC. In vitro selection of resistance to four β-lactams and azithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother 1998; 42: 2914-18.